--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its preliminary* fourth quarter and full year 2024 global net product ...
Product development is an important area in financial services and it's specifically crucial when it comes to investment management. Determining what asset management fund products will be ...